{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:28:18Z","timestamp":1761989298571,"version":"3.37.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T00:00:00Z","timestamp":1546819200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12917-018-1767-7","type":"journal-article","created":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T13:47:06Z","timestamp":1546955226000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Critically appraised topic for the most effective and safe treatment for canine generalised demodicosis"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8241-907X","authenticated-orcid":false,"given":"Roberta","family":"Perego","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Spada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Foppa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Proverbio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,7]]},"reference":[{"key":"1767_CR1","unstructured":"Miller V, Griffin C, Campbell K. Canine Demodicosis. In: Muller & Kirk\u2019s small animal dermatology. 7th ed. St. Louis: Published by Elsevier; 2013. p. 304\u201313."},{"issue":"2","key":"1767_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1365-3164.2004.00344.x","volume":"15","author":"RS Mueller","year":"2004","unstructured":"Mueller RS. Treatment protocols for demodicosis: an evidence-based review. Vet Dermatol. 2004;15(2):75\u201389. https:\/\/doi.org\/10.1111\/j.1365-3164.2004.00344.x .","journal-title":"Vet Dermatol"},{"issue":"6","key":"1767_CR3","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/S0195-5616(99)50136-8","volume":"29","author":"M Paradis","year":"1999","unstructured":"Paradis M. New approaches to the treatment of canine Demodicosis. Vet Clin N Am Small Anim Pract. 1999;29(6):1425\u201336. https:\/\/doi.org\/10.1016\/S0195-5616(99)50136-8 .","journal-title":"Vet Clin N Am Small Anim Pract"},{"issue":"1","key":"1767_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0304-4017(83)90023-7","volume":"13","author":"SD Folz","year":"1983","unstructured":"Folz SD, Kratzer DD, Conklin RD Jr, Nowakowski LH, Kakuk TJ, Rector DL. Chemotherapeutic treatment of naturally acquired generalized demodicosis. Vet Parasitol. 1983;13(1):85\u201393.","journal-title":"Vet Parasitol"},{"issue":"12","key":"1767_CR5","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.2460\/javma.1995.207.12.1581","volume":"207","author":"WH Miller","year":"1995","unstructured":"Miller WH, Scott DW, Wellington JR, Panic R. Clinical efficacy of increased dosages of milbemycin oxime for treatment of generalized demodicosis in adult dogs. J Am Vet Med Assoc. 1995;207(12):1581\u20134.","journal-title":"J Am Vet Med Assoc"},{"issue":"4","key":"1767_CR6","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1365-3164.1996.tb00248.x","volume":"7","author":"Z Ristic","year":"1996","unstructured":"Ristic Z, Medleau L, Paradis M, White-Weithers NE. Daily ivermectin for treatment of generalized demodicosis in dogs. Vet Dermatol. 1996;7(4):209\u201312.","journal-title":"Vet Dermatol"},{"issue":"4","key":"1767_CR7","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1046\/j.1365-3164.2003.00339.x","volume":"14","author":"B Holm","year":"2003","unstructured":"Holm B. Efficacy of milbemycin oxime in the treatment of canine generalized demodicosis: a retrospective study of 99 dogs (1995-2000). Vet Dermatol. 2003;14(4):189\u201395.","journal-title":"Vet Dermatol"},{"issue":"1","key":"1767_CR8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00436-005-1450-3","volume":"97","author":"J Heine","year":"2005","unstructured":"Heine J, Krieger K, Dumont P, Hellmann K. Evaluation of the efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spot-on in the treatment of generalized demodicosis in dogs: results of a European field study. Parasitol Res. 2005;97(1):89\u201396.","journal-title":"Parasitol Res"},{"issue":"1","key":"1767_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1590\/S0102-09352006000100006","volume":"58","author":"E Delayte","year":"2006","unstructured":"Delayte E, Otsuka M, Larsson CE, Castro CC. Efic\u00e1cia das lactonas macroc\u00edclicas sist\u00eamicas (ivermectina e moxidectina) na terapia da demodicidose canina generalizada. Arquivo Brasileiro de Medicina Veterinaria e Zootecnia. 2006;58(1):31\u20138.","journal-title":"Arquivo Brasileiro de Medicina Veterinaria e Zootecnia"},{"issue":"3","key":"1767_CR10","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.vetpar.2007.08.047","volume":"150","author":"LJ Fourie","year":"2007","unstructured":"Fourie LJ, Kok DJ, du Pessis A, Rugg D. Efficacy of a novel formulation of metaflumizone plus amitraz for the treatment of demodectic mange in dogs. Vet Parasitol. 2007;150(3):268\u201374.","journal-title":"Vet Parasitol"},{"issue":"1","key":"1767_CR11","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00436-009-1502-1","volume":"105","author":"LJ Fourie","year":"2009","unstructured":"Fourie LJ, Delport PC, Fourie LJ, Heine J, HOrak IG, Krieger KJ. Comparative efficacy and safety of two treatment regimens with a topically applied combination of imidacloprid and moxidectin (advocate\u00ae) against generalised demodicosis in dogs. Parasitol Res. 2009;105(1):115\u201324.","journal-title":"Parasitol Res"},{"issue":"2","key":"1767_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1136\/vr.b4885","volume":"167","author":"N Murayama","year":"2010","unstructured":"Murayama N, Shibata L, Nagata M. Efficacy of weekly oral doramectin treatment in canine demodicosis. Vet Rec. 2010;167(2):63\u20134.","journal-title":"Vet Rec"},{"issue":"2","key":"1767_CR13","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0304-4017(00)00357-5","volume":"93","author":"R Wagner","year":"2000","unstructured":"Wagner R, Wendlberger U. Field efficacy of moxidectin in dogs and rabbits naturally infested with Sarcoptes spp., Demodex spp. and Psoroptes spp. mites. Vet Parasitol. 2000;93(2):149\u201358.","journal-title":"Vet Parasitol"},{"key":"1767_CR14","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1051\/parasite\/2013046","volume":"20","author":"LJ Fourie","year":"2013","unstructured":"Fourie LJ, Dumont P, Halos L, Beugnet F, Pollmeier M. Efficacy of a topical application of Certifect \u00ae (fipronil 6.26% w\/v, amitraz 7.48% w\/v, (S)-methoprene 5.63% w\/v) for the treatment of canine generalized demodicosis. Parasite. 2013;20:46.","journal-title":"Parasite"},{"key":"1767_CR15","first-page":"5","volume":"26","author":"J Hutt","year":"2015","unstructured":"Hutt J, Prior IC, Shipstone MA. Treatment of canine generalized demodicosis using weekly injections of doramectin: 232 cases in the USA (2002-2012). Vet Dermatol. 2015;26:5.","journal-title":"Vet Dermatol"},{"issue":"5\u20136","key":"1767_CR16","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/j.1365-3164.2009.00803.x","volume":"20","author":"T Paterson","year":"2009","unstructured":"Paterson T, Halliwell RE, Fields PJ, Louw ML, Louw JP, Ball GS, Pinckney RD, McKibben JS. Treatment of canine-generalized demodicosis: a blind, randomized clinical trial comparing the efficacy of advocate (Bayer animal health) with ivermectin. Vet Dermatol. 2009;20(5\u20136):447\u201355.","journal-title":"Vet Dermatol"},{"issue":"3\u20134","key":"1767_CR17","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.vetpar.2014.08.021","volume":"205","author":"T Paterson","year":"2014","unstructured":"Paterson T, Halliwell RE, Fields PJ, Louw ML, Ball G, Louw J, Pinckney R. Canine generalized demodicosis treated with varying doses of a 2.5% moxidectin+10% imidacloprid spot-on and oral ivermectin: Parasiticidal effects and long-term treatment outcomes. Vet Parasitol. 2014;205(3\u20134):687\u201396.","journal-title":"Vet Parasitol"},{"key":"1767_CR18","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s13071-015-0775-8","volume":"8","author":"LJ Fourie","year":"2015","unstructured":"Fourie LJ, Liebenber JE, HOrak IG, Taenzler J, Heckeroth AR, Frenais R. Efficacy of orally administered fluralaner (Bravecto) or topically applied imidacloprid\/moxidectin (advocate\u00ae) against generalized demodicosis in dogs. Parasit Vectors. 2015;8:187.","journal-title":"Parasit Vectors"},{"key":"1767_CR19","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.vetpar.2016.02.027","volume":"222","author":"R Six","year":"2016","unstructured":"Six R, Becskei C, Mazaleski MM, Fourie JJ, Mahabir SP, Myers MR. Slootmans N.. efficacy of sarolaner, a novel oral isoxazoline, against two common mite infestations in dogs: Demodex spp. and Otodectes cynotis. Vet Parasitol. 2016;222:62\u20136.","journal-title":"Vet Parasitol"},{"key":"1767_CR20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1051\/parasite\/2016014","volume":"23","author":"F Beugnet","year":"2016","unstructured":"Beugnet F, Halos L, Larsen D, de Vos C. Efficacy of oral afoxolaner for the treatment of canine generalised demodicosis. Parasite. 2016;23:14.","journal-title":"Parasite"},{"issue":"1","key":"1767_CR21","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1186\/s13071-017-2472-2","volume":"10","author":"DE Snyder","year":"2017","unstructured":"Snyder DE, Wiseman S, Liebenberg JE. Efficacy of lotilaner (Credelio\u2122), a novel oral isoxazoline against naturally occurring mange mite infestations in dogs caused by Demodex spp. Parasit Vectors. 2017;10(1):532.","journal-title":"Parasit Vectors"},{"key":"1767_CR22","doi-asserted-by":"publisher","unstructured":"Cordero AM, Quek S, Mueller R. Doramectin in the treatment of generalized demodicosis. Vet Dermatol. 2018. https:\/\/doi.org\/10.1111\/vde.12515 .","DOI":"10.1111\/vde.12515"},{"key":"1767_CR23","doi-asserted-by":"publisher","unstructured":"Becskei C, Cuppens O, Mahabir SP. Efficacy and safety of sarolaner against generalized demodicosis in dogs in European countries: a non-inferiority study. Vet Dermatol. 2018. https:\/\/doi.org\/10.1111\/vde.12526 .","DOI":"10.1111\/vde.12526"},{"key":"1767_CR24","doi-asserted-by":"publisher","unstructured":"Duangkaew L, Larsuprom L, Anukkul P, Lekcharoensuk C, Chen C. A field trial in Thailand of the efficacy of oral fluralaner for the treatment of dogs with generalized demodicosis. Vet Dermatol. 2018. https:\/\/doi.org\/10.1111\/vde.12524 .","DOI":"10.1111\/vde.12524"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-018-1767-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12917-018-1767-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-018-1767-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T21:27:06Z","timestamp":1720906026000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-018-1767-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,7]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1767"],"URL":"https:\/\/doi.org\/10.1186\/s12917-018-1767-7","relation":{},"ISSN":["1746-6148"],"issn-type":[{"type":"electronic","value":"1746-6148"}],"subject":[],"published":{"date-parts":[[2019,1,7]]},"assertion":[{"value":"9 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not needed or relevant.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not needed or relevant.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"17"}}